Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Hans-Georg Klingemann"'
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 3, Iss Suppl B, Pp 123-127 (1992)
Despite the use of high dose chemoradiotherapy for the treatment of acute leukemia. relapse continues to be a major cause of death in patients given an autologous bone marrow transplant. Further augmentation of pretransplant chemotherapy causes life
Externí odkaz:
https://doaj.org/article/8923e433cd774d05aaff836d899d3ff3
Autor:
Sven Becker, Barbara Uherek, Winfried S. Wels, Hans-Georg Klingemann, Christoph Uherek, Barbara S. Schnierle, Torsten Tonn
Publikováno v:
Blood. 100:1265-1273
The continuously growing natural killer (NK) cell line NK-92 is highly cytotoxic against malignant cells of various origins without affecting normal human cells. Based on this selectivity, the potential of NK-92 cells for adoptive therapy is currentl
Publikováno v:
DNA and Cell Biology. 18:565-571
Recruitment of lymphocytes is an important feature of the host immune response against pathogens. However, the mechanisms by which lymphocytes are attracted are not yet fully understood. Recently, the cDNA of a lymphocyte-specific chemokine, lymphota
In 1988 we presented our Guide to Bone Marrow Transplan tation. The reception has been enthusiastic and we have re ceived a flood of critical comments, suggestions and requests to provide an update in due time. Although several books on marrow tr
In the late 1940s investigators observed that mice given supralethai doses of total body irradiation were protected by infusion of viable spleen or marrow cells following irradiation, and that this was accomplished by hemopoietic reconsti tution wi
The first edition to A Guide to Bone Marrow Transplantation was published 10 years ago. At that time we perceived a need for an introductory text to the area of marrow transplantation, a rapidly developing field with few general texts avail able. S
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 3, Iss Suppl B, Pp 123-127 (1992)
Despite the use of high dose chemoradiotherapy for the treatment of acute leukemia. relapse continues to be a major cause of death in patients given an autologous bone marrow transplant. Further augmentation of pretransplant chemotherapy causes life
Autor:
Guitta Maki, Torsten Tonn, Winfried S. Wels, Annemarie Schimpf, Christoph Uherek, Kai Uwe Chow, Tina Müller, Hans-Georg Klingemann
Publikováno v:
Cancer immunology, immunotherapy : CII. 57(3)
Despite the clinical success of CD20-specific antibody rituximab, malignancies of B-cell origin continue to present a major clinical challenge, in part due to an inability of the antibody to activate antibody-dependent cell-mediated cytotoxicity (ADC
Publikováno v:
Journal of hematotherapystem cell research. 11(2)
Chronic lymphocytic leukemia (CLL) cells express the CD20 antigen, and monoclonal antibodies against CD20 have resulted in remissions. We hypothezised that the anti-CD20 antibody rituximab (Rituxan) may be useful in reducing the number of contaminati
Autor:
Edmund K. Waller, Andrew Daly, Richard Herrmann, Hans-Georg Klingemann, P.J. Martin, Joseph P. Uberti, Partow Kebriaei, Robert J. Soiffer
Publikováno v:
Biology of Blood and Marrow Transplantation. 16:S169-S170